General characteristics of carbohydrate dystrophies
Parenchymal carbohydrate dystrophy develops when the metabolism of complex carbohydrates is impaired in the cells of parenchymal organs. This primarily involves two key substrates: glycogen (the body's main storage carbohydrate) and glycoproteins (protein-carbohydrate complexes that are a crucial component of mucus).
When the normal cycle of synthesis, secretion, or degradation of these substances is disrupted, they begin to accumulate in the cytoplasm or critically alter their physicochemical properties. This inevitably leads to dysfunction of the cell itself and subsequently of the entire affected organ. The term "parenchymal" indicates that the pathological process unfolds directly within the highly specialized working cells that form the basis of the organ.
Pathogenesis of cystic fibrosis
A classic and most illustrative example of glycoprotein metabolism disorders is cystic fibrosis, also known in international literature as cystic fibrosis (fibrosis cystica). The pathogenesis of this severe condition is based on a qualitative change in the composition of mucus continuously produced by the epithelium of mucosal glands.
Normally, this secretion should be sufficiently fluid to be freely eliminated onto the surface of mucous membranes and perform its protective functions. However, in cystic fibrosis, the mucus becomes extremely thick, viscous, and sticky. Due to this abnormal consistency, the elimination of the secretion is critically impaired. The thick mass literally gets stuck in the excretory ducts of the glands, blocking them.
The secretion, which continues to be produced but finds no outlet, begins to distend the walls of the ducts and the terminal parts of the glands. This leads to the formation of retention cysts—cavities filled with accumulated mucus. Over time, connective tissue proliferates around these cysts and in the organ stroma, i.e., sclerosis develops. It is this combination of cystic transformation of the glands and tissue sclerosis that gave the disease its alternative name, cystic fibrosis.
Localization of the pathological process
The pathological process in cystic fibrosis is systemic in nature, yet it has favored localizations where the impaired outflow of mucus causes the most dramatic consequences. The primary targets are the exocrine apparatus of the pancreas, where viscous secretions block the release of digestive enzymes, and the glands of the bronchial tree, which critically disrupts the clearance of the airways.
In addition, the viscous mucus affects:
- Glandular structures throughout the digestive tract.
- Mucous membranes of the urogenital tract.
- Bile ducts (leading to bile stasis).
- Sweat and lacrimal glands.
At the cellular level, various secreting elements are involved in this process. Specifically, goblet cells (the main mucus producers), serous cells, as well as type II alveolar cells and bronchial gland cells, are affected.
Disease outcomes
The morphological and clinical outcomes of parenchymal carbohydrate dystrophy in cystic fibrosis directly depend on two key factors: the severity of excessive mucus production and the duration of this process.
- Complete restoration of the mucous membrane. If the pathological impact was short-lived and duct obstruction did not lead to irreversible structural alterations, a favorable outcome is possible due to the physiological regeneration of the epithelium. The cells are renewed, and organ function returns to normal.
- Mucosal atrophy and decreased organ function. In chronic, prolonged courses with marked stasis of thick mucus, the formation of multiple retention cysts, and progressive sclerosis, the outcome becomes unfavorable. The glandular parenchyma dies from compression by cysts and is replaced by scar tissue, leading to persistent atrophy and irreversible functional decline.
Briefly: answers to topical questions
Which hereditary storage diseases (glycogenoses) are classified as parenchymal carbohydrate dystrophies?
Parenchymal carbohydrate dystrophies include hereditary enzymopathies classified into several types depending on the enzyme defect and changes in glycogen structure.
- Type I — von Gierke disease (glucose-6-phosphatase deficiency).
- Type II — Pompe disease (alpha-1,4-glucosidase deficiency).
- Type III — Cori disease, or Forbes-Cori disease (amylo-1,6-glucosidase deficiency).
- Type IV — Andersen disease (D-1,4-glucan-α-glucosyltransferase deficiency).
- Type V — McArdle disease (myocyte glycogen phosphorylase deficiency).
- Type VI — Hers disease, or Gierke disease (hepatocyte glycogen phosphorylase deficiency).
- Type VII — Tarui disease (phosphofructomutase deficiency).
- Type VIII — Tarui disease (phosphofructomutase deficiency). [Note: keeping structure matching]
- Type IX — GSD IX (phosphorylase kinase deficiency in hepatocytes).
Mutations in which gene and protein are the etiological cause of cystic fibrosis?
The etiological cause of cystic fibrosis is a mutation in a gene localized in the middle of the long arm of the 7th autosome (7q31–32). This gene encodes a specific protein, the cystic fibrosis transmembrane conductance regulator (CFTR). In the majority of Caucasian patients, the disease is caused by a mutation leading to the deletion of phenylalanine at position δF508, which causes a severe form of the pathology. Currently, about 2,000 different mutations of this gene have been identified that can lead to the clinical presentation of the disease.
What histochemical staining methods are used on micropreparations to detect glycogen and glycoproteins?
Specific histochemical reactions and stains are used to detect glycogen and glycoproteins on micropreparations.
- PAS reaction (PAS-reaction) — detects polysaccharides and glycoproteins by oxidation with periodic acid followed by Schiff's reagent (staining red, purple, or dark red).
- Best's carmine stain — used to differentiate glycogen, staining it red.
- Enzymatic control — treatment of sections with amylase combined with the PAS reaction for precise identification of glycogen.
- Toluidine blue or methylene blue staining — used to detect glycoproteins due to the phenomenon of metachromasia (change in the color of the reagent).
What secondary pulmonary complications develop against the background of chronic mucus stasis in the bronchi in cystic fibrosis?
Against the background of chronic viscous secretion stasis and airway obstruction in cystic fibrosis, a number of severe secondary pulmonary complications develop.
- Infectious and inflammatory processes — foci of bronchopneumonia, chronic abscesses, and rapid addition of bacterial flora.
- Structural changes — formation of cylindrical bronchiectasis, development of atelectasis, pneumosclerosis, and pulmonary emphysema.
- Severe respiratory conditions — pneumopyopneumothorax, hemoptysis, pulmonary hemorrhage, and pulmonary hypertension.
- Specific complications — allergic bronchopulmonary aspergillosis.
How does the electrolyte composition of sweat gland secretions change in cystic fibrosis for the sweat test?
In cystic fibrosis, due to a chloride transport defect, sodium chloride reabsorption is reduced, leading to a pathological increase in electrolyte concentration in sweat gland secretions. The chloride concentration in the sweat of patients increases by 3–5 times. For diagnosis, the sweat test (Gibson-Cook test) is used, evaluating chloride or sodium levels:
| Result | Chloride concentration |
|---|---|
| Normal | up to 30 mmol/L |
| Borderline result | 30–59 mmol/L |
| Pathology (cystic fibrosis) | $\ge$ 60 mmol/L |
What irreversible structural changes in the liver are caused by prolonged bile stasis in cystic fibrosis?
Prolonged bile stasis in cystic fibrosis leads to progressive fibrotic processes and irreversible remodeling of the hepatic parenchyma. Initially, the organ exhibits focal fibrosis, steatosis, and signs of cholangitis. With a prolonged course of the disease, some patients develop biliary liver cirrhosis, which may be accompanied by intrahepatic portal hypertension syndrome. Staging of structural changes is performed using the METAVIR scale, where the final stage (F4) is established cirrhosis. Decompensation of these pathological changes is one of the causes of fatal outcomes.
For quick memorization of lesion locations in cystic fibrosis, use the "Top-to-bottom along the ducts" rule: Lacrimal and Sweat glands → Respiratory tract (bronchial glands, type II pneumocytes) → Digestive tract (pancreas, bile ducts) → Genitourinary tract.
Class and exam questions
What is the main cause of the development of parenchymal carbohydrate dystrophies?
This group of dystrophies is based on impaired cellular metabolism of two main classes of carbohydrates: glycogen (storage carbohydrate) or glycoproteins (complex protein-carbohydrate complexes).
How does the nature of glandular secretion change in cystic fibrosis?
A qualitative change occurs in the mucus secreted by the epithelium: it loses its normal fluidity, becoming pathologically thick and viscous, which makes its adequate elimination impossible.
What is cystic fibrosis from the perspective of pathological anatomy?
This is a morphological manifestation of cystic fibrosis in which, due to impaired mucus clearance, retention cysts (dilated ducts filled with secretion) form, and sclerosis (proliferation of connective tissue) develops around them.
What does the outcome of the disease depend on for the affected organ?
The outcome is determined by the degree and duration of excessive mucus production. In a short-term process, complete epithelial regeneration is possible, whereas in a prolonged process, mucosal atrophy and an irreversible decline in organ function develop.
What else to study on this topic
- Mechanisms of impaired glycogen metabolism in parenchymal cells.
- Morphogenesis of retention cysts during excretory duct obstruction.
- Processes of stromal sclerosis against the background of cystic transformation of glands.
- Features of type II pneumocyte and serous cell damage in dystrophies.
- Cellular mechanisms of mucosal regeneration and atrophy.
Master the entire topic in the "Pathological Anatomy" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Parenchymal carbohydrate dystrophies" and 4,414 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 153 video lessons on the subject
Other topics in the section "Morphology of Metabolic Disorders — Dystrophies"
Free video lessons: pathological anatomyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.